In this study, we will demonstrate that the
epicardium drug delivery system for bone marrow stem cells (EDDS & BMSCs)
can treat heart failure.
24 rats were
randomly allocated into four groups and six animals in each group as
follows: Normal group, heart failure after myocardial infarction (HF after MI)
group, EDDS and EDDS & BMSCs group. EDDS were implanted in SD rat with post-infarction
dilated heart failure.
The bone marrow stem cells, which were
delivered by the device of subcutaneous tube at post operation seventh days,
fifteenth days and twenty-fifth days.
